[
  {
    "title": "惠泰医疗(688617.SH)：已累计耗资5999.05万元回购31.18万股",
    "href": "http://stock.jrj.com.cn/2023/01/03201137256475.shtml",
    "datetime": "2023-01-03 20:11:56",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：董事徐轶青完成减持0.75%股份",
    "href": "http://stock.jrj.com.cn/2022/12/30183637250514.shtml",
    "datetime": "2022-12-30 18:36:58",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：66.68万股限售股将于1月9日解禁",
    "href": "http://stock.jrj.com.cn/2022/12/28191837243998.shtml",
    "datetime": "2022-12-28 19:18:25",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：拟使用不超7.88亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/12/14202437213113.shtml",
    "datetime": "2022-12-14 20:24:02",
    "code": "688617"
  },
  {
    "title": "惠泰医疗6名股东合计减持350万股 套现合计9.84亿 2022年前三季度公司净利2.61亿",
    "href": "http://stock.jrj.com.cn/2022/12/08191237199221.shtml",
    "datetime": "2022-12-08 19:12:05",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：启明维创及其一致行动人QM33已完成减持2.7273%的股份",
    "href": "http://stock.jrj.com.cn/2022/12/08170637198620.shtml",
    "datetime": "2022-12-08 17:06:03",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：启明创智及其一致行动人已完成减持2.5224%的股份",
    "href": "http://stock.jrj.com.cn/2022/12/08170537198624.shtml",
    "datetime": "2022-12-08 17:05:03",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：董事、副总经理徐轶青已减持28.1768万股",
    "href": "http://stock.jrj.com.cn/2022/12/05171037189142.shtml",
    "datetime": "2022-12-05 17:10:42",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)截至11月底已累计回购31.1808万股",
    "href": "http://stock.jrj.com.cn/2022/12/01170637181815.shtml",
    "datetime": "2022-12-01 17:06:44",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：减持数过半 启明创智及其一致行动人、启明维创及其一致行动已减持合计3.95%股份",
    "href": "http://stock.jrj.com.cn/2022/11/24172637164121.shtml",
    "datetime": "2022-11-24 17:26:49",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：启明创智及其一致行动人持股比例由11.02%减至10.01%",
    "href": "http://stock.jrj.com.cn/2022/11/16163537143767.shtml",
    "datetime": "2022-11-16 16:35:05",
    "code": "688617"
  },
  {
    "title": "惠泰医疗：启明融科等多位股东拟合计减持不超400.01万股公司股份",
    "href": "http://stock.jrj.com.cn/2022/11/03100537108930.shtml",
    "datetime": "2022-11-03 10:05:24",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：若干股东拟减持合计不超5.9998%股份",
    "href": "http://stock.jrj.com.cn/2022/11/02172837107009.shtml",
    "datetime": "2022-11-02 17:28:07",
    "code": "688617"
  },
  {
    "title": "惠泰医疗2022年前三季度净利2.61亿同比增长60.82% 销售规模增长",
    "href": "http://stock.jrj.com.cn/2022/10/27111137088733.shtml",
    "datetime": "2022-10-27 11:11:35",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：第三季度净利增115.59%至1.02亿元",
    "href": "http://stock.jrj.com.cn/2022/10/26154737085586.shtml",
    "datetime": "2022-10-26 15:47:49",
    "code": "688617"
  },
  {
    "title": "A股异动 | 惠泰医疗涨停 料前三季度净利同比增52.44%到68.49%",
    "href": "http://stock.jrj.com.cn/2022/10/17094037059367.shtml",
    "datetime": "2022-10-17 09:40:39",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：预计前三季度净利同比增加52.44%到68.49%",
    "href": "http://stock.jrj.com.cn/2022/10/16182137058486.shtml",
    "datetime": "2022-10-16 18:21:05",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：截至9月底已累计回购31.18万股",
    "href": "http://stock.jrj.com.cn/2022/10/10154137043806.shtml",
    "datetime": "2022-10-10 15:41:50",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617)：以集中竞价交易方式回购公司股份",
    "href": "http://stock.jrj.com.cn/2022/09/02091436965796.shtml",
    "datetime": "2022-09-02 09:14:20",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)截至8月底已累计回购0.4557%的股份",
    "href": "http://stock.jrj.com.cn/2022/09/01184736963853.shtml",
    "datetime": "2022-09-01 18:47:20",
    "code": "688617"
  },
  {
    "title": "惠泰医疗披露2022年半年报 实现营收5.56亿元",
    "href": "http://stock.jrj.com.cn/2022/08/30092436950959.shtml",
    "datetime": "2022-08-30 09:24:44",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)半年度净利润1.59亿元、同比增长38.33%",
    "href": "http://stock.jrj.com.cn/2022/08/29165436947672.shtml",
    "datetime": "2022-08-29 16:54:58",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617)：股东减持计划时间届满暨减持股份结果",
    "href": "http://stock.jrj.com.cn/2022/08/25085736933961.shtml",
    "datetime": "2022-08-25 08:57:36",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：减持期届满 启明创智等股东均未减持股份",
    "href": "http://stock.jrj.com.cn/2022/08/24213736932244.shtml",
    "datetime": "2022-08-24 21:37:43",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)截至7月底已累计回购14.3772万股",
    "href": "http://stock.jrj.com.cn/2022/08/01154536859194.shtml",
    "datetime": "2022-08-01 15:45:39",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：7月8日首次回购9.51万股",
    "href": "http://stock.jrj.com.cn/2022/07/08153736794417.shtml",
    "datetime": "2022-07-08 15:37:50",
    "code": "688617"
  },
  {
    "title": "惠泰医疗将花不超1亿元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2022/06/22195236750773.shtml",
    "datetime": "2022-06-22 19:52:37",
    "code": "688617"
  },
  {
    "title": "收购少数股权的原因及必要性？惠泰医疗回复问询函",
    "href": "http://stock.jrj.com.cn/2022/06/21101636745218.shtml",
    "datetime": "2022-06-21 10:16:22",
    "code": "688617"
  },
  {
    "title": "标的公司资不抵债且亏损，惠泰医疗近6亿元收购造富员工？",
    "href": "http://stock.jrj.com.cn/2022/06/18084536740008.shtml",
    "datetime": "2022-06-18 08:45:00",
    "code": "688617"
  },
  {
    "title": "拟收购子公司剩余股权 惠泰医疗被问询：有必要吗？",
    "href": "http://stock.jrj.com.cn/2022/06/16122436733982.shtml",
    "datetime": "2022-06-16 12:24:36",
    "code": "688617"
  },
  {
    "title": "说明收购少数股权的原因及必要性？惠泰医疗收上交所问询函",
    "href": "http://stock.jrj.com.cn/2022/06/16094436733416.shtml",
    "datetime": "2022-06-16 09:44:11",
    "code": "688617"
  },
  {
    "title": "惠泰医疗：拟使用5.86亿收购上海宏桐少数股东股权",
    "href": "http://stock.jrj.com.cn/2022/06/15133336730699.shtml",
    "datetime": "2022-06-15 13:33:56",
    "code": "688617"
  },
  {
    "title": "惠泰医疗：实控人、董事长提议斥资5000万-1亿元回购股份",
    "href": "http://stock.jrj.com.cn/2022/06/15133136730702.shtml",
    "datetime": "2022-06-15 13:31:26",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：拟约5.857亿元收购上海宏桐剩余37.33%股权",
    "href": "http://stock.jrj.com.cn/2022/06/14203036728980.shtml",
    "datetime": "2022-06-14 20:30:26",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：拟斥0.5亿元-1亿元回购公司股份",
    "href": "http://stock.jrj.com.cn/2022/06/14202136728951.shtml",
    "datetime": "2022-06-14 20:21:37",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617)：股东减持股份时间过半暨减持进展",
    "href": "http://stock.jrj.com.cn/2022/05/25084036676205.shtml",
    "datetime": "2022-05-25 08:40:55",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：大股东及董监高减持期过半未减持",
    "href": "http://stock.jrj.com.cn/2022/05/24175136674785.shtml",
    "datetime": "2022-05-24 17:51:21",
    "code": "688617"
  },
  {
    "title": "惠泰医疗2022年第一季度净利6680.61万同比增长41.55% 销售收入实现较快增长",
    "href": "http://stock.jrj.com.cn/2022/05/03193236546567.shtml",
    "datetime": "2022-05-03 19:32:40",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：一季度净利润增41.55%至6680.61万元",
    "href": "http://stock.jrj.com.cn/2022/04/28182336494155.shtml",
    "datetime": "2022-04-28 18:23:34",
    "code": "688617"
  },
  {
    "title": "惠泰医疗董秘增持公司股份200万元 构成“窗口期”违规交易",
    "href": "http://stock.jrj.com.cn/2022/04/28122436491793.shtml",
    "datetime": "2022-04-28 12:24:54",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)2021年度权益分派10派10元 股权登记日为4月18日",
    "href": "http://stock.jrj.com.cn/2022/04/12211236317673.shtml",
    "datetime": "2022-04-12 21:12:23",
    "code": "688617"
  },
  {
    "title": "惠泰医疗2021年净利2.08亿同比增长87.7% 董事长成正辉薪酬254.49万",
    "href": "http://stock.jrj.com.cn/2022/03/10223634811344.shtml",
    "datetime": "2022-03-10 22:36:09",
    "code": "688617"
  },
  {
    "title": "惠泰医疗：2021年度归母净利同比增87.7%至2.08亿元，拟每10股派10元",
    "href": "http://stock.jrj.com.cn/2022/03/10213634811153.shtml",
    "datetime": "2022-03-10 21:36:04",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：2021年净利增87.70%至2.08亿元 拟10派10元",
    "href": "http://stock.jrj.com.cn/2022/03/10210634811059.shtml",
    "datetime": "2022-03-10 21:06:18",
    "code": "688617"
  },
  {
    "title": "A股异动 | 惠泰医疗(688617.SH)涨5.7% 料前两月营收同比增70%",
    "href": "http://stock.jrj.com.cn/2022/03/10100334807472.shtml",
    "datetime": "2022-03-10 10:03:42",
    "code": "688617"
  },
  {
    "title": "顺利实现“开门红”！惠泰医疗预计今年前2月营收1.56亿元左右",
    "href": "http://stock.jrj.com.cn/2022/03/10095434807425.shtml",
    "datetime": "2022-03-10 09:54:27",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：1-2月实现营收1.56亿元左右 同比增长约70%",
    "href": "http://stock.jrj.com.cn/2022/03/09175134574799.shtml",
    "datetime": "2022-03-09 17:51:30",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：外周球囊扩张导管取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/03/02172434512691.shtml",
    "datetime": "2022-03-02 17:24:21",
    "code": "688617"
  },
  {
    "title": "惠泰医疗2021年净利2.07亿 同比增加86% 生产制造环节降本增效",
    "href": "http://stock.jrj.com.cn/2022/02/24205234453391.shtml",
    "datetime": "2022-02-24 20:52:05",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：子公司获得三项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/02/21163034422629.shtml",
    "datetime": "2022-02-21 16:30:29",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：2021年度净利润预增73.32%-88.67%",
    "href": "http://stock.jrj.com.cn/2022/01/27184834231616.shtml",
    "datetime": "2022-01-27 18:48:15",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：启明创智、韩永贵等股东拟减持合计不超4.55%股份",
    "href": "http://stock.jrj.com.cn/2022/01/26204034224988.shtml",
    "datetime": "2022-01-26 20:40:39",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：2998.15万股限售股将于2022年1月7日解禁上市",
    "href": "http://stock.jrj.com.cn/2021/12/28181234077184.shtml",
    "datetime": "2021-12-28 18:12:20",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：拟使用不超9亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/12/15164034019773.shtml",
    "datetime": "2021-12-15 16:40:39",
    "code": "688617"
  },
  {
    "title": "惠泰医疗净利倍增股价涨超3倍 医工结合自主研发掌握核心技术",
    "href": "http://stock.jrj.com.cn/2021/11/25074433917254.shtml",
    "datetime": "2021-11-25 07:44:42",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：第三季度净利增50.00%至4717.46万元",
    "href": "http://stock.jrj.com.cn/2021/10/28161733769145.shtml",
    "datetime": "2021-10-28 16:17:12",
    "code": "688617"
  },
  {
    "title": "A股异动 | 中期营收净利实现双增长 惠泰医疗(688617.SH)大涨逾8%",
    "href": "http://stock.jrj.com.cn/2021/08/25143233315898.shtml",
    "datetime": "2021-08-25 14:32:16",
    "code": "688617"
  },
  {
    "title": "惠泰医疗2021年半年度净利1.15亿元 同比净利增加186.24%",
    "href": "http://stock.jrj.com.cn/2021/08/24180533311051.shtml",
    "datetime": "2021-08-24 18:05:51",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：上半年净利增186.24%至1.15亿元",
    "href": "http://stock.jrj.com.cn/2021/08/24173833310745.shtml",
    "datetime": "2021-08-24 17:38:09",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：子公司取得一项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/07/26165633152711.shtml",
    "datetime": "2021-07-26 16:56:38",
    "code": "688617"
  },
  {
    "title": "惠泰医疗2021年上半年预计净利1.07亿-1.17亿增加166%-191% 国内市场需求得到恢复",
    "href": "http://stock.jrj.com.cn/2021/06/30201633023385.shtml",
    "datetime": "2021-06-30 20:16:49",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：上半年净利预增166.66%到191.59%",
    "href": "http://stock.jrj.com.cn/2021/06/30171133022267.shtml",
    "datetime": "2021-06-30 17:11:03",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：约60.78万股首发限售股7月7日解禁",
    "href": "http://stock.jrj.com.cn/2021/06/28170333010590.shtml",
    "datetime": "2021-06-28 17:03:32",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)拟参与认购泰誉三期基金1500万元基金份额",
    "href": "http://stock.jrj.com.cn/2021/05/31200132852023.shtml",
    "datetime": "2021-05-31 20:01:25",
    "code": "688617"
  },
  {
    "title": "惠泰医疗：2020年年度权益分派实施 每10股派发现金红利5元（含税）",
    "href": "http://stock.jrj.com.cn/2021/05/31092532847528.shtml",
    "datetime": "2021-05-31 09:25:36",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)拟10派5元 股权登记日6月3日",
    "href": "http://stock.jrj.com.cn/2021/05/30162832841137.shtml",
    "datetime": "2021-05-30 16:28:42",
    "code": "688617"
  },
  {
    "title": "惠泰医疗：公司已于2021年1月15日获得三维心脏电生理标测系统的注册证",
    "href": "http://stock.jrj.com.cn/2021/05/14080832752720.shtml",
    "datetime": "2021-05-14 08:08:13",
    "code": "688617"
  },
  {
    "title": "惠泰医疗去年赚1.11亿元 拟派现3333.50万元",
    "href": "http://stock.jrj.com.cn/2021/04/27113632461027.shtml",
    "datetime": "2021-04-27 11:36:30",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)2020年归母净利增长34.15%至1.11亿元 拟10派5元",
    "href": "http://stock.jrj.com.cn/2021/04/26212732456571.shtml",
    "datetime": "2021-04-26 21:27:19",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：一季度净利4719.5万元 同比增长439.94%",
    "href": "http://stock.jrj.com.cn/2021/04/26212332456561.shtml",
    "datetime": "2021-04-26 21:23:22",
    "code": "688617"
  },
  {
    "title": "惠泰医疗：今年埃普特三月上旬在手订单量均是去年同期2倍多",
    "href": "http://stock.jrj.com.cn/2021/04/13101832363204.shtml",
    "datetime": "2021-04-13 10:18:29",
    "code": "688617"
  },
  {
    "title": "惠泰医疗：公司球囊在多个省市以第一顺位中标之后对其他产品入院销售起到一定的正向推动作用",
    "href": "http://stock.jrj.com.cn/2021/04/13101832363202.shtml",
    "datetime": "2021-04-13 10:18:22",
    "code": "688617"
  },
  {
    "title": "惠泰医疗：公司IPO募投项目的产销符合预期",
    "href": "http://stock.jrj.com.cn/2021/04/13101832363203.shtml",
    "datetime": "2021-04-13 10:18:03",
    "code": "688617"
  },
  {
    "title": "惠泰医疗：外周二代微导管与一代相比出厂价与毛利率均有提升",
    "href": "http://stock.jrj.com.cn/2021/04/13101632363196.shtml",
    "datetime": "2021-04-13 10:16:53",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)拟推2021年限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2021/04/06201932320657.shtml",
    "datetime": "2021-04-06 20:19:31",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：子公司取得一项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/02/25172032026269.shtml",
    "datetime": "2021-02-25 17:20:15",
    "code": "688617"
  },
  {
    "title": "惠泰医疗2020年度净利1.11亿增长34.2% 医院手术需求量逐步恢复",
    "href": "http://stock.jrj.com.cn/2021/02/24191232020105.shtml",
    "datetime": "2021-02-24 19:12:04",
    "code": "688617"
  },
  {
    "title": "为避免股权被稀释，惠泰医疗子公司埃普特拟认购瑞康通55.31万元注册资本",
    "href": "http://stock.jrj.com.cn/2021/02/09134631876897.shtml",
    "datetime": "2021-02-09 13:46:07",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)与关联方共同投资及部分放弃优先认购权",
    "href": "http://stock.jrj.com.cn/2021/02/08192731871732.shtml",
    "datetime": "2021-02-08 19:27:51",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：2020年7月至今累计获1045.23万元政府补助",
    "href": "http://stock.jrj.com.cn/2021/02/08192431871719.shtml",
    "datetime": "2021-02-08 19:24:30",
    "code": "688617"
  },
  {
    "title": "惠泰医疗：不存在同业竞争",
    "href": "http://stock.jrj.com.cn/2021/02/04131931848196.shtml",
    "datetime": "2021-02-04 13:19:55",
    "code": "688617"
  },
  {
    "title": "惠泰医疗：覆盖了包括胸主动脉支架和腔静脉滤器在内的多个研发项目",
    "href": "http://stock.jrj.com.cn/2021/02/04130631848153.shtml",
    "datetime": "2021-02-04 13:06:19",
    "code": "688617"
  },
  {
    "title": "惠泰医疗：磁定位冷盐水灌注射频消融电极导管获医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/02/01114331828494.shtml",
    "datetime": "2021-02-01 11:43:20",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：控股子公司获得一项医疗器械注册证 涉三维心脏电生理标测系统",
    "href": "http://stock.jrj.com.cn/2021/01/22172131745908.shtml",
    "datetime": "2021-01-22 17:21:42",
    "code": "688617"
  },
  {
    "title": "惠泰医疗：惠泰医疗将致力于在心脑血管微创介入领域的发展",
    "href": "http://stock.jrj.com.cn/2021/01/22150031744722.shtml",
    "datetime": "2021-01-22 15:00:37",
    "code": "688617"
  },
  {
    "title": "惠泰医疗：公司将根据业务需求和战略布局 对研发中心的布局进行动态调整",
    "href": "http://stock.jrj.com.cn/2021/01/22150031744723.shtml",
    "datetime": "2021-01-22 15:00:10",
    "code": "688617"
  },
  {
    "title": "惠泰医疗：全资子公司埃普特收到两项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/01/19141631721611.shtml",
    "datetime": "2021-01-19 14:16:02",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)取得两项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/01/18154731715330.shtml",
    "datetime": "2021-01-18 15:47:50",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：拟使用部分募集资金向子公司提供借款 实施募投项目",
    "href": "http://stock.jrj.com.cn/2021/01/18154731715332.shtml",
    "datetime": "2021-01-18 15:47:06",
    "code": "688617"
  },
  {
    "title": "惠泰医疗使用11亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/invest/2021/01/08100731672486.shtml",
    "datetime": "2021-01-08 10:07:00",
    "code": "688617"
  },
  {
    "title": "惠泰医疗使用11亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/invest/2021/01/08100731654048.shtml",
    "datetime": "2021-01-08 10:07:00",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：拟使用不超11亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/01/07190231649603.shtml",
    "datetime": "2021-01-07 19:02:44",
    "code": "688617"
  },
  {
    "title": "科创板迎2021年首家医药生物企业 惠泰医疗上市首日收涨245.18%",
    "href": "http://stock.jrj.com.cn/2021/01/07180931649135.shtml",
    "datetime": "2021-01-07 18:09:03",
    "code": "688617"
  },
  {
    "title": "中一签赚10万！1.1万股民乐了 “化工茅台”市值超万科",
    "href": "http://stock.jrj.com.cn/2021/01/07123631647128.shtml",
    "datetime": "2021-01-07 12:36:05",
    "code": "688617"
  },
  {
    "title": "1月7日上市新股：博俊科技、江天化学、惠泰医疗",
    "href": "http://stock.jrj.com.cn/2021/01/07091631645921.shtml",
    "datetime": "2021-01-07 09:16:00",
    "code": "688617"
  },
  {
    "title": "[中金公司]中金公司助力惠泰医疗在科创板成功上市",
    "href": "http://stock.jrj.com.cn/2021/01/07000031654776.shtml",
    "datetime": "2021-01-07 00:00:00",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：公司股票1月7日起上市交易",
    "href": "http://stock.jrj.com.cn/2021/01/05192231636040.shtml",
    "datetime": "2021-01-05 19:22:32",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)披露上市发行结果：遭弃购6330股 由联席主承销商包销",
    "href": "http://stock.jrj.com.cn/2021/01/03151731621789.shtml",
    "datetime": "2021-01-03 15:17:48",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：中信证券投资获配66.68万股 网上摇号中签号共11369个",
    "href": "http://stock.jrj.com.cn/2020/12/29195831597156.shtml",
    "datetime": "2020-12-29 19:58:11",
    "code": "688617"
  },
  {
    "title": "【兑奖啦】惠泰医疗网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2020/12/29192931597004.shtml",
    "datetime": "2020-12-29 19:29:27",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：网上发行最终中签率为0.02952215%",
    "href": "http://stock.jrj.com.cn/2020/12/28191231587888.shtml",
    "datetime": "2020-12-28 19:12:22",
    "code": "688617"
  },
  {
    "title": "今日新股申购：惠泰医疗",
    "href": "http://stock.jrj.com.cn/2020/12/28085731584250.shtml",
    "datetime": "2020-12-28 08:57:00",
    "code": "688617"
  },
  {
    "title": "[惠泰医疗]CIT2019|雄关漫道真如铁,而今迈步从头越——APT助力国产PCI手术器械新发展",
    "href": "http://stock.jrj.com.cn/2020/12/26000031690608.shtml",
    "datetime": "2020-12-26 00:00:00",
    "code": "688617"
  },
  {
    "title": "惠泰医疗(688617.SH)：发行价定为74.46元/股 12月28日申购",
    "href": "http://stock.jrj.com.cn/2020/12/24194631563223.shtml",
    "datetime": "2020-12-24 19:46:53",
    "code": "688617"
  },
  {
    "title": "证监会同意奥普特、之江生物、惠泰医疗科创板IPO注册",
    "href": "http://stock.jrj.com.cn/2020/12/08190331442104.shtml",
    "datetime": "2020-12-08 19:03:00",
    "code": "688617"
  },
  {
    "title": "惠泰医疗IPO迷离：3年19次监管检查不合格 大客户与实控人关系非同寻常",
    "href": "http://stock.jrj.com.cn/2020/11/12083031265504.shtml",
    "datetime": "2020-11-12 08:30:00",
    "code": "688617"
  },
  {
    "title": "惠泰医疗招股书显示子公司2019年负债“激增” 募资8.4亿元拟推动血管介入产业化升级 | 产业新股",
    "href": "http://stock.jrj.com.cn/2020/09/09190430712880.shtml",
    "datetime": "2020-09-09 19:04:56",
    "code": "688617"
  },
  {
    "title": "四方光电、惠泰医疗9月8日科创板首发上会",
    "href": "http://stock.jrj.com.cn/2020/08/31091030641013.shtml",
    "datetime": "2020-08-31 09:10:00",
    "code": "688617"
  },
  {
    "title": "[惠泰医疗]全民战“疫”(三)关爱妇儿健康:妇儿相关疾病的介入治疗研讨",
    "href": "http://stock.jrj.com.cn/2020/03/16000031690615.shtml",
    "datetime": "2020-03-16 00:00:00",
    "code": "688617"
  },
  {
    "title": "[惠泰医疗]全民战“疫”(一)爱不隔离:特殊时期,介入科医生防护与管理",
    "href": "http://stock.jrj.com.cn/2020/02/25000031690621.shtml",
    "datetime": "2020-02-25 00:00:00",
    "code": "688617"
  },
  {
    "title": "[惠泰医疗]刚柔并济,指随心意-埃普特医疗 Instantpass微导管“温暖”京城",
    "href": "http://stock.jrj.com.cn/2019/11/26000031690617.shtml",
    "datetime": "2019-11-26 00:00:00",
    "code": "688617"
  },
  {
    "title": "[惠泰医疗]埃普特Instantpass微导管亮相2019第二届中国出血大会",
    "href": "http://stock.jrj.com.cn/2019/11/05000031690602.shtml",
    "datetime": "2019-11-05 00:00:00",
    "code": "688617"
  },
  {
    "title": "[惠泰医疗]刚柔并济,指随心意—埃普特医疗Instantpass微导管“花开”十三朝古都-西安",
    "href": "http://stock.jrj.com.cn/2019/11/05000031690600.shtml",
    "datetime": "2019-11-05 00:00:00",
    "code": "688617"
  },
  {
    "title": "[惠泰医疗]“刚柔并济,指随心意” ——埃普特医疗Instantpass微导管“闪耀”郑州",
    "href": "http://stock.jrj.com.cn/2019/10/30000031690613.shtml",
    "datetime": "2019-10-30 00:00:00",
    "code": "688617"
  },
  {
    "title": "[惠泰医疗]刚柔并济,指随心意—埃普特医疗Instantpass微导管“花开”北国春城",
    "href": "http://stock.jrj.com.cn/2019/10/21000031690607.shtml",
    "datetime": "2019-10-21 00:00:00",
    "code": "688617"
  },
  {
    "title": "[惠泰医疗]埃普特医疗Instantpass外周微导管亮相2019CET",
    "href": "http://stock.jrj.com.cn/2019/09/09000031690619.shtml",
    "datetime": "2019-09-09 00:00:00",
    "code": "688617"
  },
  {
    "title": "[惠泰医疗]笃行致远 逐梦扬帆——远端桡动脉“大拇指”俱乐部正式成立",
    "href": "http://stock.jrj.com.cn/2019/09/02000031690604.shtml",
    "datetime": "2019-09-02 00:00:00",
    "code": "688617"
  },
  {
    "title": "[惠泰医疗]BFIS 2019 | “刚柔并济 指随心意” Instantpass微导管病例演讲大赛",
    "href": "http://stock.jrj.com.cn/2019/09/02000031690611.shtml",
    "datetime": "2019-09-02 00:00:00",
    "code": "688617"
  },
  {
    "title": "[惠泰医疗]楚天舒,见初心——埃普特长缨工作导丝上市会成功举办",
    "href": "http://stock.jrj.com.cn/2019/07/05000031690603.shtml",
    "datetime": "2019-07-05 00:00:00",
    "code": "688617"
  },
  {
    "title": "[惠泰医疗]刚柔并济,指随心意—— Instantpass外周微导管上市启动会(广州站)",
    "href": "http://stock.jrj.com.cn/2019/07/03000031690601.shtml",
    "datetime": "2019-07-03 00:00:00",
    "code": "688617"
  },
  {
    "title": "[惠泰医疗]豫初心 视未来 ——AnyreachC工作导丝(长缨)上市会",
    "href": "http://stock.jrj.com.cn/2019/07/01000031690606.shtml",
    "datetime": "2019-07-01 00:00:00",
    "code": "688617"
  },
  {
    "title": "[惠泰医疗]OCC2019丨花开今日 逐梦今朝——TransportaGe导引导管上市启动会燃动OCC之夜",
    "href": "http://stock.jrj.com.cn/2019/06/25000031690620.shtml",
    "datetime": "2019-06-25 00:00:00",
    "code": "688617"
  },
  {
    "title": "[惠泰医疗]“曲颈向天歌”埃普特医疗携天鹅颈系列微导管亮相CCI2019",
    "href": "http://stock.jrj.com.cn/2019/05/06000031690612.shtml",
    "datetime": "2019-05-06 00:00:00",
    "code": "688617"
  },
  {
    "title": "[惠泰医疗]CCIO 2019 |埃普特医疗午间卫星会 “刚柔并济,指随心意”",
    "href": "http://stock.jrj.com.cn/2019/04/07000031690618.shtml",
    "datetime": "2019-04-07 00:00:00",
    "code": "688617"
  }
]